About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Proteomic Assessment of Preterm Birth

NCT01371019·13 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sera Prognostics, Inc.

Age

18–60

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Subject is 18 years or older.
Subject has a singleton pregnancy.
Subject is able to provide consent.

You may not be if

Subject is pregnant with more than one fetus.
There is a known or suspected fetal anomaly.

The record

StatusCompleted

PhaseNo phase

Taking part5,500

StartedApr 2011

UpdatedJun 11, 2015

Conditions

Where13

Maricopa Integrated Health System
Phoenix, Arizona, United States
San Diego Perinatal Clinic
San Diego, California, United States
Christiana Care Health System
Newark, Delaware, United States

Clareo Health | Proteomic Assessment of Preterm Birth